EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Overview of Endomucin in Vascular Homeostasis and Disease

Rui-Fan Yang iD, Xiao-Rong Wang, Jing Wang, Hui-Bo Du, Zhen-Ao Zhao iD, Zi-Gang Zhao iD

Microcirculation · 2026-10 · 33 (7)

DOI: 10.1111/micc.70083 ↗

At a glance

Übersichtsarbeit in Microcirculation, published online on 2026-08-28. Written by Rui-Fan Yang and 5 co-authors. Institution: Institute of Microcirculation & Basic Medical College, Hebei North University, Zhangjiakou, Hebei, China. Major MEDLINE topics: Sialomucins, Homeostasis. 64 references. The full text is freely available in PubMed Central. Funded by: Innovation Capacity Training Funding Program for Master's Degree Candidates in the Hebei Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Endomucin (EMCN), a highly glycosylated type I transmembrane sialomucin, is predominantly expressed on the luminal surface of venous and capillary endothelial cells and serves as a critical guardian of vascular homeostasis and immunological silencing. Its highly extended, O‐glycosylated extracellular domain provides significant steric hindrance and electrostatic repulsion, functioning as a dual physical barrier that prevents nonspecific leukocyte tethering and adhesion. Beyond its anti‐adhesive role, EMCN is a pivotal orchestrator of angiogenesis, modulating the vascular endothelial growth factor signaling cascade by facilitating vascular endothelial growth factor receptor 2 autophosphorylation at the Y1175 residue and subsequent receptor internalization. Furthermore, EMCN has emerged as a specialized marker for type H vessels and human hematopoietic stem cells, playing indispensable roles in vessel‐bone coupling and hematopoietic development. Clinical evidence indicates that the dysregulation of EMCN expression or post‐translational modifications contributes to the pathogenesis of diabetic complications, atherosclerosis, bone metabolic disorders, and tumor metastasis. This review systematically summarizes structural characteristics, expression patterns, and multifaceted biological functions of EMCN, providing a theoretical foundation for the development of novel therapeutic strategies for microvascular and metabolic diseases.

Subjects

MeSH terms (MEDLINE)

SialomucinsHomeostasisHumansAnimalsNeovascularization, Pathologic

Author keywords

angiogenesisendomucininflammatory responsetype H vesselsvascular permeability

Substances

Sialomucins

Authors and institutions

  • Institute of Microcirculation & Basic Medical College, Hebei North University, Zhangjiakou, Hebei, China.
  • Hebei Key Laboratory of Critical Disease Mechanism and Intervention, Zhangjiakou, Hebei, China.
  • Hebei Key Laboratory of Critical Disease Mechanism and Intervention, Shijiazhuang, Hebei, China.
  • Zhangjiakou Key Laboratory of Microcirculation and Shock, Zhangjiakou, Hebei, China.
  • Medical College, Zhangjiakou University, Zhangjiakou, Hebei, China.

ORCID profiles: Rui-Fan Yang, Zhen-Ao Zhao, Zi-Gang Zhao

Funding

  • Innovation Capacity Training Funding Program for Master's Degree Candidates in the Hebei Province

Cite

APA

Yang, R. F., Wang, X. R., Wang, J., Du, H. B., Zhao, Z. A., & Zhao, Z. G. (2026). Overview of Endomucin in Vascular Homeostasis and Disease. Microcirculation, 33(7). https://doi.org/10.1111/micc.70083

Vancouver

Yang RF, Wang XR, Wang J, Du HB, Zhao ZA, Zhao ZG. Overview of Endomucin in Vascular Homeostasis and Disease. Microcirculation. 2026;33(7). doi:10.1111/micc.70083

BibTeX
@article{Yang2026,
  author = {Yang, Rui-Fan and Wang, Xiao-Rong and Wang, Jing and Du, Hui-Bo and Zhao, Zhen-Ao and Zhao, Zi-Gang},
  title = {Overview of Endomucin in Vascular Homeostasis and Disease},
  journal = {Microcirculation},
  year = {2026},
  volume = {33},
  number = {7},
  doi = {10.1111/micc.70083}
}
Start for free →